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A B S T R A C T   
Mastitis remains the most expensive disease of dairy cows, and antibiotic dry cow therapy (DCT) at dry-off is an 
important part of mastitis control. Regardless of the infection status, blanket DCT is administered to all quarters 
of all cows, which is controversial due to the worldwide problem of antimicrobial resistance. Even though se-
lective DCT of only infected cows is a more sustainable approach, choosing animals for treatment is not always 
straightforward. Our aim was to evaluate whether the herd-level DCT approach is associated with early lactation 
udder health problems, taking into account the cow characteristics. The information source was 2015–2017 
Dairy Herd Improvement data with 7461 multiparous cows from 241 Finnish dairy herds. Information on the 
herd-level DCT approach was obtained from farmers’ questionnaire responses in 2017, and the three different 
approaches were selective DCT, blanket DCT, and no DCT. The statistical tool for the data analysis was a 
generalized linear mixed model with a random herd effect for binary outcomes and a linear mixed model with a 
random herd effect for a continuous outcome. The two binary outcomes were the odds of having high milk 
somatic cell count (SCC ≥ 200 000 cells/mL) on the first test-day within 5–45 days in milk (DIM) and the odds of 
mastitis treatment in early lactation up to 45 DIM. The third outcome was the mean milk lnSCC (× 1000 cells/ 
mL) within 120 DIM. Selective DCT was the prevailing treatment practice in our data. Blanket DCT was asso-
ciated with lower SCC after calving. Cows more likely to have high SCC after calving were older cows, cows with 
high average SCC during the previous lactation, and cows with high milk yield near dry-off. A mastitis treatment 
in the early lactation was more likely if, during the previous lactation, the cow had high average SCC, high peak 
milk production, or high milk yield near dry-off. Our findings indicate that DCT is still effective in mastitis 
control. Cows with high milk yield, especially near dry-off, and cows with persistently high SCC require attention 
when considering next lactation udder health.   
1. Introduction 
Antibiotic dry cow therapy (DCT) effectively reduces the prevalence 
of bacterial intramammary infections (IMI) in dairy cows (Dingwell 
et al., 2003; Bradley and Green, 2004). The susceptibility of cows to 
mastitis particularly during the dry period and the large economic 
impact of mastitis emphasize the importance of DCT (Bradley and 
Green, 2004; Halasa et al., 2007). The DCT is administered either as a 
blanket treatment of all quarters of all cows or as a selective treatment of 
only infected cows or quarters. The use of non-antibiotic internal or 
external teat sealants (ITS, ETS) either alone or concurrently with DCT is 
an additional preventive measure against IMI (Rabiee and Lean, 2013; 
Winder et al., 2019a). The basis for treating all cows at dry-off was 
established over five decades ago in the 5-point mastitis plan against 
contagious pathogens (Neave et al., 1969), and blanket DCT is still a 
widely used tool in mastitis control around the world. Nevertheless, the 
Nordic guidelines for mastitis therapy have always recommended se-
lective DCT, use of narrow-spectrum antibiotics, and a microbiological 
diagnosis of infected quarters (Ekman and Østerås, 2003; Vilar et al., 
2018; Rajala-Schultz et al., 2019). 
Globally, environmental mastitis pathogens are the most common 
causes for mastitis in modern dairy herds, and instead of antibiotics, the 
emphasis is on other mastitis prevention measures (Klaas and Zadoks, 
2018). Furthermore, given the increasingly serious problem of 
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antimicrobial resistance, it is not surprising that the use of antibiotics in 
dairy farming is a topic of an active discussion (World Health Organi-
zation, 2014, 2015; European Commission, 2015; EMA and EFSA, 
2017). Despite the concerns towards antibiotic use in animal produc-
tion, studies on mastitis pathogens have not shown a clear rise in the 
prevalence of resistance (Saini et al., 2012; de Jong et al., 2018). 
However, we have only limited knowledge about the intramammary 
microbiome and the transfer of resistance features within animal 
microbiomes, which consist mostly of commensal bacteria (Pärnanen 
et al., 2018). Already the manufacturing process of drugs produces 
harmful levels of antibiotic emissions, and together with the use of an-
tibiotics, this most likely increases the selection pressure for resistance 
(Levy and Marshall, 2004; Larsson et al., 2007; Perry and Wright, 2013; 
Surette and Wright, 2017). Therefore, unnecessary administration of 
antibiotics is unsustainable, and the optimization of use is important for 
controlling the antibiotic consumption and release of antibiotic residues 
(Laxminarayan et al., 2013; Pruden et al., 2013), as also emphasized by 
the One Health approach (McEwen and Collignon, 2018). Since anti-
biotic DCT products account for a large proportion of drugs used in 
mastitis control, the use and efficacy of DCT in modern dairy herds are 
worth re-examining (Pol and Ruegg, 2007; Scherpenzeel et al., 2014; 
Vanhoudt et al., 2018). 
Cow composite milk somatic cell count (SCC) is an easily obtained 
numeric value from the Dairy Herd Improvement (DHI) test-day mea-
surements. A composite milk SCC of a healthy udder is typically < 100 
000 cell/mL (Sordillo et al., 1997). The widely used threshold for IMI 
detection is SCC ≥ 200 000 cell/mL, and cows with SCC above this 
threshold are more likely to have IMI (Dohoo and Leslie, 1991; Schepers 
et al., 1997; Djabri et al., 2002; Pantoja et al., 2009b). The reported 
sensitivity and specificity of the latter threshold range from 0.64 to 0.89 
and from 0.66 to 0.90, respectively (McDermott et al., 1982; Dohoo and 
Leslie, 1991; Schepers et al., 1997; Pantoja et al., 2009b). Sensitivity and 
specificity vary mainly due to the pathogen involved, the number of 
infected quarters, the time of milk sampling, and the limitations in 
bacteriological examination of milk. Intramammary infections caused 
by minor pathogens typically elicit more moderate SCC responses than 
those caused by major pathogens (Barkema et al., 1999). 
Since the most challenging question of selective DCT is how to find 
the cows to be treated, studies have utilized test-day SCC information to 
find out the selection criteria for infected cows (Torres et al., 2008; 
Rajala-Schultz et al., 2011; Vasquez et al., 2018; Rowe et al., 2020b). 
Additionally, studies have used test-day SCC information in the evalu-
ation of the infection dynamics across the dry period (Cook et al., 2002; 
Pantoja et al., 2009b; Madouasse et al., 2010; Dufour and Dohoo, 2012; 
Lipkens et al., 2019a, b). However, as the long-term use of selective DCT 
is so far limited mainly to the Nordic countries, observational studies in 
commercial dairy herds that utilize DHI data to compare different DCT 
approaches are scarce (Vanhoudt et al., 2018; Niemi et al., 2020). 
Using retrospective DHI data, our objective was to determine 
whether the herd-level DCT approach is associated with early lactation 
udder health problems while taking into account the effect of cow 
characteristics. 
2. Materials and methods 
2.1. DHI data 
Our initial data included DHI information from 22 270 cows regis-
tered in 241 conventional dairy herds during 2015–2017. Farmers 
responded to an online questionnaire in 2017. The questionnaire was 
available to all dairy farmers who belonged to the Finnish dairy herd 
recording system (equivalent to DHI) in 2016. During that year, 
approximately 70 % of Finnish herds and 80 % of Finnish cows belonged 
to the system. The responding farms amounted to 715 out of approxi-
mately 5400. Vilar et al. (2018) reported the information from the 
questionnaire. The farms included in this study granted permission to 
use their DHI data for research, and the data source was the Finnish Milk 
Recording database (MTech Digital Solutions, Vantaa, Finland). Niemi 
et al. (2020) reported the detailed herd-level information of these farms 
from 2012 to 2016. 
DHI data included cow-level information on test-day SCC and milk 
production. Although the test-day interval for milk production mea-
surements was typically one month, the usual interval for SCC mea-
surements was either one or two months. For a small proportion of cows, 
test-day measurements were available at a two-week interval. Further-
more, data included information on 305-d milk production, 305-d en-
ergy-corrected milk production (ECM305), days in milk on a test-day 
(DIM), breed, parity, dry period length and recording of mastitis treat-
ments. Data comprised only two predominant dairy breeds in Finland, 
Finnish Ayrshire and Holstein, which at the time of the study accounted 
for approximately 98 % of the national dairy population. 
Farmers in Finland do not have access to antibiotic drugs without a 
prescription from a veterinarian. Thus, mastitis treatments are either 
given by a veterinarian or initiated based on veterinary advice. These 
treatments are recorded into a central health-recording database. The 
treatment records during lactation are classified as clinical and sub-
clinical mastitis, but do not contain information on the clinical symp-
toms of mastitis or the severity of the symptoms. Consequently, all 
records of mastitis treatments were taken into account and were defined 
as a mastitis treatment during lactation. Dry cow therapy has a separate 
code. In some farms, the mandatory individual dry-cow treatment re-
cords are only stored on the farm and are not transferred to the dairy 
herd recording system. As a result, DHI data lacked reliable data on 
individual dry-cow treatments. 
2.2. Exclusion criteria 
After the exclusion of primiparous cows (n = 9047) and cows without 
test-day SCC measures (n = 1764), the latest calving was selected for 
every cow. DHI information comprised the early lactation after the 
calving and the entire preceding lactation. Cows with a dry period < 30 
days or > 90 days were excluded (n = 1394) because those lengths were 
not considered representative of a typical dry period. Approximately 4 % 
of the cows lacked information on the date of dry-off. Therefore, cows 
with test-day measures within 40 days before calving and missing dry- 
off date (n = 48) were excluded due to the likelihood of an unusually 
short dry-period. Conversely, cows without test-day measures within 
120 days before calving and missing dry-off date (n = 37) were excluded 
due to the likelihood of an unusually long dry period. Cows without a 
test-day SCC within 45 days post calving (n = 2046) were excluded to 
ensure that the first SCC-measurement was not too far from calving. 
Cows with a test-day SCC within 5 days post calving (n = 473) were 
excluded, because the first SCC measurement was considered being too 
shortly after calving (Barkema et al., 1999). Subsequently to the ex-
clusions, the cows numbered 7461, and the herds numbered 241. 
2.3. Antibiotic DCT strategies 
The data comprised information on the herd-level DCT approach 
based on farmers’ questionnaire answers between January and May 
2017 (Vilar et al., 2018). Duration of the DCT approach used by the farm 
without changing the selected approach was from 1 to 5 years in 51 
farms and over 5 years in 190 farms (Niemi et al., 2020). The type of 
DCT approach was a compulsory question and the three DCT-treatment 
categories were selective DCT, blanket DCT, and no DCT. In order to 
minimize misclassification bias, dry-off dates of the cows were between 
November 2015 and December 2017. Based on the questionnaire in-
formation, 73.4 % (141/192) of the selective DCT farms treated only up 
to 25 % their cows with DCT, and only 9.4 % (18/192) of these farms 
treated more than half of their cows at dry-off (Niemi et al., 2020). At the 
time of the study, the three antibiotic dry cow products on the Finnish 
market contained benzylpenicillin 400 000 IU and framycetin 100 mg 
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(Umpimycin vet, Boehringer Ingelheim Vetmedica GmbH, Germany), 
cloxacillin 500 mg (Orbenin retard vet, Zoetis Finland Oy, Finland), and 
ampicillin 250 mg and cloxacillin 500 mg (Kloxerate retard, Norbrook 
Laboratories Limited, Ireland). 
2.4. Management of missing values 
The effect of missing values on data analysis was as follows. The 
mean SCC of the previous lactation was calculated from the test-day 
measurements, and it was based on a minimum of five and maximum 
of 27 measurements. This measure was available from 6825 cows on 239 
herds. The peak milk production during 0–120 d in the previous lacta-
tion was sought among the test-day milk production measures. This 
measure was missing from one cow. The calculated mean SCC during the 
early lactation, 5–120 DIM, was based on a minimum of two and 
maximum of eight measurements. This measure was available from 
6187 cows on 240 herds. Dry period length was available from 7211 
cows on 240 herds. 
2.5. The approximation of late lactation milk production 
Because the last test-day with milk production measure ranged from 
34 to 153 days prior to calving, the measurements were not directly 
comparable. Therefore, for the 7461 cows, late lactation milk produc-
tion was approximated on the median of the last test-day with milk 
production measure. This median of the last test-day was 79 days before 
calving. The approximation method was the following. The last four test- 
day milk measurements during the previous lactation were included for 
every cow, and each cow had to have minimum of two milk measure-
ments. For all milk measurements used, the DIM was greater than 120 to 
ensure that the values were on the decreasing phase of a typical lactation 
curve (Macciotta et al., 2005). Based on these measures, a linear 
regression was fit for every cow. Due to the notable variability in the 
test-day intervals and the slopes of these linear regressions, the mean 
slope was averaged from all slopes. This mean slope was -0.10 kg/day 
decline in milk production in the late lactation. The linear approxima-
tion of milk production on day 79 before calving was performed through 
the cow’s own last milk measurement 34–153 days prior to calving. The 
slope of this linear approximation was the described average milk 
decline of our data. The tool for approximation was R version 4.0.0 (R 
Core Team, 2018) using R Studio Version 1.3.959 (RStudio Team, 2020). 
2.6. Statistical analysis 
The early lactation udder health was evaluated with three different 
statistical models. The outcome of the first model was the odds of having 
milk SCC ≥ 200 000 cells/mL on the first test-day 5–45 DIM (binary). 
The outcome of the second model was the odds of mastitis treatment 
within 45 DIM (binary). The outcome of the third model was the mean 
milk lnSCC (× 1000 cells/mL) during 5–120 DIM (continuous). Data 
exploration was conducted according to the protocol described by Zuur 
et al. (2010). The unconditional analyses of the main effects and the 
analyses of the first-order interactions were carried out between the 
explanatory variables and the outcome variables. The statistical model 
for the continuous outcome was a linear mixed model (LMM) with a 
random herd effect and for the binary outcomes a generalized linear 
mixed model (GLMM) with logit link function and a random herd effect. 
The likelihood ratio tests indicated that the random herd effect 
contributed significantly to a better model fit (p-value < 0.0001). 
Three explanatory variables represented the preceding lactation 
udder health. These variables were mean lnSCC (× 1000 cells/mL) of the 
lactation (continuous), SCC (× 1000 cells/mL) on the last test-day 0–60 
d before dry-off (categorical with three levels: < 100, 100–250, > 250), 
and the number of mastitis treatments during the lactation (categorical 
with three levels: 0, 1, ≥ 2). Although the three variables were associ-
ated (p-value < 0.01) with the outcomes in the unconditional analysis, 
the inter-association of the variables indicated noticeable collinearity. 
Therefore, only the mean lnSCC of the previous lactation was considered 
in the further analysis. This variable, unlike the others, described the 
udder health of the preceding lactation over a longer period. 
The explanatory variables that represented the preceding lactation 
milk production were peak milk production during 0–120 DIM (× 5 kg/ 
d, continuous), ECM305 (× 1000 kg, continuous), and approximated 
milk production 79 d before calving (× 5 kg/d, continuous). These 
variables were associated (p-value < 0.05) with the outcome variables in 
the unconditional analyses. The correlation between the peak milk 
production and the ECM305 was high (Pearson’s r = 0.84). The corre-
lation between approximated milk production 79 d before calving and 
ECM305 was low (Pearson’s r = 0.36), and the correlation between 
approximated milk production 79 d before calving and the peak milk 
production was negligible (Pearson’s r = 0.21). Taking into account the 
correlations, the variables considered in the further analyses were 
approximated milk production 79 d before calving and the peak milk 
production during 0–120 DIM in the previous lactation. 
Other explanatory variables were DCT approach of the farm (cate-
gorical with three levels: selective DCT, blanket DCT, no DCT), DIM (×
30 d) on the last milk production measurement at the end of lactation 
(continuous), parity at calving (categorical with three levels: 2, 3, ≥ 4), 
dry period length (× 30 d, continuous), and breed (categorical with two 
levels: Finnish Ayrshire, Holstein). The variables that were associated 
with all outcomes in the unconditional analyses were DCT approach (p- 
value < 0.1) and parity (p-value < 0.01). DIM on the last milk- 
measurement before dry-off was associated (p-value < 0.2) with the 
odds of having SCC ≥ 200 000 cells/mL on the first test-day 5–45 DIM 
and the mean milk lnSCC (× 1000 cells/mL) during 5–120 DIM. Breed 
was associated (p-value < 0.001) with the odds of mastitis treatment 
within 45 DIM and with the mean lnSCC (× 1000 cells/mL) during 
5–120 DIM. 
Explanatory variables that were associated with the outcome were 
introduced to the respective full model with the manual backward 
elimination model-building procedure to identify statistically significant 
explanatory variables (p-value < 0.05) of the final models. The DCT 
approach was included in the models regardless of whether it was sta-
tistically significant or not, as it was the main explanatory variable. 
When the outcome was the odds of mastitis treatment within 45 DIM, 
parity was forced into the final model as a confounding variable for the 
relationship between peak milk production and the outcome, mastitis. 
The mastitis treatment between 0–45 d after calving (categorical with 
two levels: yes, no) was included in the final model, when the mean 
lnSCC during 5–120 DIM was the outcome. DIM at first SCC- 
measurement after calving (categorical with seven levels) was tested 
as an explanatory variable in the model for the odds of having milk SCC 
≥ 200 000 cells/mL on the first test-day 5–45 DIM. This variable did not 
have any effect on the coefficients of other explanatory variables and 
was thus omitted from the final model. 
Model validation indicated that all models complied with underlying 
assumptions. In order to measure the goodness-of-fit, marginal and 
conditional coefficients of determination were calculated for the models 
using methodology described by Nakagawa and Schielzeth (2013) and 
Nakagawa et al. (2017). The coefficients of determination represent the 
proportion of variance explained by fixed effects, and fixed and random 
effects together. For GLMMs fitted to the binomial distribution, the 
described methods are the theoretical method (assumes the 
observation-scale variance is constant, π2/3) and the delta method 
(approximates the observation-scale variance based on the data) 
(Nakagawa et al., 2017). As a final step, 10 000 data sets were randomly 
simulated from the three final models separately to verify that the 
models complied with the observed data. The percentage of zeros was 
calculated for each simulated data sets from binomial GLMMs and were 
compared with the respective percentage of zeros in the observed 
binomial outcome variables. The comparison indicated that the models 
could cope with the number of zeros in the data. The density curves of 
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the simulated data sets from the LMM were compared with the density 
curve of the observed mean milk lnSCC (× 1000 cells/mL) to verify that 
the simulated data did not divert too much from observed data. Statis-
tical analyses were done with R version 4.0.0 (R Core Team, 2018) using 
R Studio Version 1.3.959 (RStudio Team, 2020) with the package lme4 
(Bates et al., 2015). The package ggplot2 (Wickham, 2016) was used to 
produce graphs. The packages MuMIn (Barton, 2020) and r2glmm 
(Jaeger, 2017) were used to calculate the marginal and conditional 
coefficients of determination. 
3. Results 
3.1. Descriptive results 
Tables 1 and 2 present the descriptive statistics of the DHI data for 
the study farms and cows. Most of the cows, 74.4 % (5550/7461), were 
from selective DCT farms, followed by 20.6 % (1539/7461) of cows 
coming from blanket DCT farms, and 5.0 % (372/7461) from no DCT 
farms. Of the 241 farms, 192 (79.7 %) were selective DCT farms, 35 
(14.5 %) were blanket DCT farms, and 14 (5.8 %) no DCT farms. The 
sample appeared representative of Finnish dairy farms, although the 
study farms had slightly larger number of cows, higher milk production 
and lower SCC than the average Finnish farms at that time (Table 1). 
Two breeds divided 50.0 % Finnish Ayrshire and 50.0 % Holstein, 
and the breed distribution was parallel across the DCT-approach groups. 
The proportion of cows with at least one mastitis treatment during the 
previous lactation was 11.2 % (838/7461), and the proportion of 
mastitis-treated cows during first 45 DIM was 7.0 % (519/7461). The 
median test-day of the last SCC-measurement was 27 d before dry-off 
and thus slightly differed from the median test-day of the last milk- 
measurement, which was 17 d before dry-off and 79 d before calving. 
The median test-day of the first SCC-measurement after calving was 22 
d. The overall proportion of all cows with SCC ≥ 200 000 cells/mL on 
the last SCC-measurement before dry-off and on the first SCC- 
measurement after calving was similar between groups except for no 
DCT group. Although the mean approximated late lactation milk pro-
duction near dry-off was approximately 20 kg/d across the DCT groups, 
the late lactation milk production of cows varied substantially. Likewise, 
305-day milk production, 305-day ECM, and peak milk production of 
the previous lactation varied noticeably, while the mean values were 
similar across the DCT groups (Table 2). 
3.2. The odds of having SCC ≥ 200 000 cells/mL after calving 
Table 3 presents the results of the final model for the odds of having 
SCC ≥ 200 000 cells/mL on the first test-day 5− 45 DIM. The OR for 
blanket DCT approach compared with selective DCT approach was 0.69 
(95 % CI 0.54– 0.88); p = 0.003. High mean SCC in the previous 
lactation increased the odds of high SCC after calving. Cows with high 
milk production near dry-off were more likely to have high SCC after 
calving, although peak milk production in the early previous lactation 
was not statistically significantly associated to the odds of having high 
SCC. Additionally, cows more likely to have high SCC after calving were 
older cows, and cows with a long previous lactation based on high DIM 
on the last test-day before dry-off. The theoretical-method marginal and 
conditional coefficients of determination showed that the proportion of 
variance in the model explained by the fixed effects was 8.9 % and the 
proportion of variance explained by the fixed and random effects 
together was 13.7 %. The respective proportions of variance for the 
delta-method marginal and conditional coefficients of determination 
were 5.4 % and 8.4 %. 
3.3. The odds of mastitis treatment after calving 
Table 4 shows the results of the final model for the odds of mastitis 
treatment within 45 DIM. The OR for blanket DCT approach compared 
with selective DCT approach was 0.67 (95 % CI 0.45–1.02); p = 0.06. 
Cows more likely to have a mastitis treatment in early lactation were 
cows with high mean SCC during the previous lactation, cows with a 
high milk yield near dry-off, and cows with a high peak milk yield in the 
previous lactation. The theoretical-method marginal and conditional 
coefficients of determination showed that the proportion of variance in 
the model explained by the fixed effects was 3.9 % and the proportion of 
variance explained by the fixed and random effects together was 16.3 %. 
The respective proportions of variance for the delta-method marginal 
and conditional coefficients of determination were 2.4 % and 10.0 %. 
3.4. Mean SCC within 120 DIM 
Table 5 presents the results of the final model for the mean SCC 
during 5–120 DIM. The prediction of early lactation mean lnSCC was 
lower if a cow was from a blanket DCT farm compared with a cow from a 
selective DCT farm. At SCC of 100 000 cells/mL this corresponds to a 
decrease of 20 000 cells/mL. The prediction of mean lnSCC was higher, 
if a cow had mastitis treatment within 45 DIM, had high mean SCC 
during the previous lactation, or if a cow was in her third, fourth or 
higher lactation. The peak milk production in the previous lactation was 
not statistically significantly associated with the mean lnSCC, but a high 
milk yield near dry-off was associated with a higher prediction of mean 
lnSCC in the first four months of the subsequent lactation. At SCC of 100 
000 cells/mL this corresponds to an increase of 8000 cells/mL for every 
5 kg increase in approximated milk production 79 d before calving. The 
Table 1 
Annual Dairy Herd Improvement (DHI) information presented from 241 conventional dairy herds in 2016 (Niemi et al., 2020).   
Selective DCTa (n = 192) Blanket DCT (n = 35) No DCT (n = 14) National databaseb  
Mean (median) Min Max Mean (median) Min Max Mean (median) Min Max Mean 
Herd size 49.5 (37.6) 13 314.7 77.9 (62.4) 15.4 254.7 46.1 (30.4) 15.7 153.7 41.5 
SCCc (x 1000 cell/mL) 160.7 (163.0) 36 336 162.9 (157.0) 49 316 155.8 (166.5) 82.0 260.0 178 
Milk productiond (kg/cow) 9693.9 (9664.5) 6693 12486 10091.4 (9944.0) 7797 11600 10094.1 (10083.0) 7788 12367 9542 
Parity 2.5 (2.5) 1.7 4.3 2.4 (2.4) 1.8 3.4 2.2 (2.3) 1.8 2.8 2.4 
Calving interval (d) 402.7 (399.5) 365 507 404.2 (402) 365 445 409.1 (410.5) 382 435 410  
Milking system Number (%) Number (%) Number (%)  
Pipeline 97 (50.5) 10 (28.6) 11 (78.6)  
AMSe 40 (20.8) 16 (45.7) 1 (7.1)  
Parlor 55 (28.7) 9 (25.7) 2 (14.3)   
a Dry cow therapy. 
b Finnish Milk Recording System (2016). 
c Somatic cell count. Annual herd-average of usually monthly or bimonthly milk SCC measurements of the individual cows. 
d Annual herd-average of usually monthly milk production measurements of the individual cows. 
e Automatic milking system. 
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marginal and conditional coefficients of determination showed that the 
proportion of variance in the model explained by the fixed effects was 
12.9 % and the proportion of variance explained by the fixed and 
random effects together was 19.0 %. The proportion of variance 
explained by mean lnSCC of the previous lactation was 7.6 %, which was 
a considerably higher proportion compared to the other fixed effects of 
the model (Table 5). 
4. Discussion 
Recent herd-level results indicate that, although considerable 
variability exists among farms, the selective-DCT farms can reach long- 
term good udder health and milk production (Vanhoudt et al., 2018; 
Niemi et al., 2020). The previously reported differences in herd-level 
SCC and milk production among the DCT-approach groups were minor 
(Niemi et al., 2020), but the current cow-level results from the same 
farms showed that high SCC after calving was less likely, if a cow was a 
blanket-DCT farm cow compared with a selective-DCT farm cow. 
Although the use of DCT may have an effect on the odds of early 
lactation mastitis treatment, this study lacked statistical evidence to find 
differences between various DCT approaches. To the best of our 
knowledge, only one retrospective, observational cow-level selective 
Table 2 
Dairy Herd Improvement (DHI) information from 7461 multiparous cows registered in 241 conventional dairy herds during 2015–2017.   
Selective DCTa (n = 5550) Blanket DCT (n = 1539) No DCT (n = 372) All cows  
Mean 
(median) 
Min Max Mean 
(median) 
Min Max Mean 
(median) 
Min Max Mean 
Parity 3.3 (3) 2 11 3.1 (3) 2 10 3.1 (3) 2 8 3.3 
Dry period lengthb 61.8 (61) 30 90 62.2 (61) 32 90 58.2 (57) 30 90 61.7 
Mean test-day SCC (× 1000 cells/mL) of the 
previous lactationc 
153.7 (75) 8.2 2915.8 157.8 (78.5) 9.8 4462 137.2 (78.6) 9.6 1650.4 153.7 
Mean test-day SCC (× 1000 cells/mL) 5–120 d after 
calvingd 
227.8 (73.5) 4 8337.5 194.9 (51) 5.5 5950.5 216.5 (81.2) 6 2282.5 220.7 




3415 16931 10052.3 
(10007) 
3808 16701 9436.2 
(9290.5) 
3913 16324 9820.4 
305-day ECM (kg) of the previous lactationf 10091.5 
(10016) 
2501 16852 10358.3 
(10333) 
4170 16561 9691.2 
(9634) 
3992 14163 10126.5 
Peak milk production (kg/d) during 0–120 d in the 
previous lactationg 
40.3 (39.8) 15.5 76.8 41.6 (41.4) 16.4 73.3 38.1 (37.2) 19.6 62.4 40.4 
Approximated milk production (kg/d) 79 d before 
calving 
20.4 (20.3) 1.6 48.0 21.3 (21.4) 3.1 40.9 21.2 (21.2) 4.3 47.5 20.6 
Days in milk (DIM) on last test-day before dry-off 318.8 (307) 207 656 317.3 (305) 218 665 320.1 (308) 228 599 318.6   
Number (%) Number (%) Number (%) Number 
(%) 
SCC ≥ 200 000 cells/mL 0− 60 d before dry-offh 1188 (23.3) 316 (22.8) 65 (19.5) 1569 
(21.0) 
SCC ≥ 200 000 cells/mL 5–45 d after calving 1347 (24.3) 292 (19.0) 101 (27.2) 1740 
(23.3) 
Mastitis treatment 0–45 d after calving 428 (7.7) 72 (4.7) 19 (5.1) 519 (7.0)  
a Dry cow therapy. 
b Number of missing values: 205 selective DCT, 39 blanket DCT, 6 no DCT, 250 all cows. 
c Based on minimum of 5 and maximum of 27 test-day measures. Number of missing values: 407 selective DCT, 183 blanket DCT, 46 no DCT, 636 all cows. 
d Somatic cell count. Based on minimum of 2 and maximum of 8 test-day measures. Number of missing values: 884 selective DCT, 300 blanket DCT, 90 no DCT, 1274 
all cows. 
e Number of missing values: 4 selective DCT, 2 blanket DCT, 6 all cows. 
f Energy-corrected milk production. Number of missing values: 5 selective DCT, 2 blanket DCT, 7 all cows. 
g Number of missing values: 1 no DCT. 
h Number of missing test-day measures: 445 selective DCT, 152 blanket DCT, 39 no DCT, 636 all cows. 
Table 3 
Model estimates from logistic regression as a generalized linear mixed model for the odds of having milk somatic cell count (SCC) ≥ 200 000 cells/mL on the first test- 
day 5–45 days in milk (DIM), based on 6825 cows from 239 dairy herds.  
Variable Category Coefficient S.E. z-value p-value OR 95 % CI 
Fixed effects 
Intercept  − 4.55 0.27 − 16.64 < 0.0001    
DCTa approach 
No DCT 0.21 0.19 1.12 0.260 1.24 0.85 1.80 
Blanket DCT − 0.36 0.12 − 2.91 0.003 0.69 0.54 0.88 
Selective DCT Ref.       
Mean lnSCC (× 1000 cells/mL) of the previous lactation  0.44 0.02 14.97 < 0.0001 1.56 1.47 1.66 
Approximated milk production 79 d before calving (× 5 kg/d)  0.10 0.02 4.45 < 0.0001 1.11 1.06 1.17 
Parity 
≥ 4 0.41 0.07 5.59 < 0.0001 1.51 1.31 1.75 
3 0.34 0.07 4.42 < 0.0001 1.41 1.21 1.64 
2 Ref.       
DIM on last test-day before dry-off (× 30 d)  0.05 0.01 3.13 0.001 1.05 1.02 1.09  
Variable  Variance S.D.      
Random effect 
Herd (Intercept)  0.184 0.429       
a Dry cow therapy. 
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DCT-usage study exists prior the current study. In agreement with our 
results, that study showed higher odds of low SCC at the first test-day 
post-calving when antibiotic DCT was administered with or without 
ITS to the cow at dry-off (Vanhoudt et al., 2018). The main limitation of 
our study is that, instead of individual cow-level DCT treatment infor-
mation, our study reports only herd-level information about the DCT 
treatments. Although the proportion of treated cows varies in selective 
DCT farms, the majority of the selective-DCT farmers of the current 
study reported treating only up to one fourth of their cows at dry-off. 
These proportions of treated cows were moderate and parallel to what 
has been reported before from the Nordic countries (Ekman and Østerås, 
2003). In the Netherlands, selective DCT has been the national practice 
only since 2012 and the reported proportions of treated cows were 
higher (Scherpenzeel et al., 2016b; Vanhoudt et al., 2018). Economi-
cally, the optimum proportion of treated cows varies among farms, and 
the assessment and advice on cows in need of antibiotic DCT should be 
herd-specific (Huijps and Hogeveen, 2007; Halasa et al., 2010; Raja-
la-Schultz et al., 2011; Scherpenzeel et al., 2016a; Gussmann et al., 
2018a; Scherpenzeel et al., 2018). 
Our findings suggest that DCT remains an effective mastitis control 
tool in modern dairy farms. In agreement, the recent meta-analysis 
compared the efficacy of selective DCT versus blanket DCT and stated 
that risk of IMI at calving was higher in selectively treated cows, but 
considerable heterogeneity indicated more between-study variation 
than would be expected by chance (Winder et al., 2019b). The findings 
align with previous meta-analyses (Robert et al., 2006; Halasa et al., 
2009). On the contrary, several experimental field studies with different 
study designs have reported that selective DCT had little or no negative 
effect on udder health and milk production on herd level (Bradley et al., 
2010; Rajala-Schultz et al., 2011; Cameron et al., 2014, 2015; Vasquez 
et al., 2018), but opposite findings also exist (Berry and Hillerton, 
2002a; McDougall, 2010; Scherpenzeel et al., 2014). The most recent 
studies combined selective DCT with concurrent ITS use, and the results 
consistently indicate that selective DCT has no negative effects on udder 
health (McParland et al., 2019; Rowe et al., 2020a, b). Compared with 
blanket DCT, the beneficial effect of selective DCT on the amount of 
antibiotics used is considerable and should not be overlooked (Pol and 
Ruegg, 2007; Scherpenzeel et al., 2014; Vanhoudt et al., 2018; Vasquez 
et al., 2018; McParland et al., 2019; Rowe et al., 2020a). Overall, DCT 
still appears to be an effective and useful tool in the management of 
udder health, but sufficient justification seems to lack for its prophy-
lactic use in healthy animals. From the practical point of view, the 
puzzling question concerns the selection of cows to be treated at dry-off 
considering udder health, economics, antimicrobial resistance, and 
Table 4 
Model estimates from logistic regression as a generalized linear mixed model for the odds of mastitis treatment within 45 days in milk (DIM), based on 6824 cows from 
239 dairy herds.  
Variable Category Coefficient S.E. z-value p-value OR 95 % CI 
Fixed effects 
Intercept  − 5.15 0.36 − 14.28 < 0.0001    
DCTa approach 
No DCT − 0.39 0.35 − 1.08 0.276 0.67 0.33 1.36 
Blanket DCT − 0.38 0.20 − 1.85 0.063 0.67 0.45 1.02 
Selective DCT Ref.       
Mean lnSCCb (× 1000 cells/mL) of the previous lactation  0.24 0.04 5.16 < 0.0001 1.28 1.16 1.40 
Approximated milk production 79 d before calving (× 5 kg/d)  0.08 0.04 2.08 0.036 1.08 1.00 1.18 
Parity 
≥ 4 − 0.27 0.17 − 1.62 0.104 0.75 0.54 1.05 
3 − 0.03 0.15 − 0.19 0.844 0.97 0.71 1.31 
2 Ref.       
Peak milk production during 0–120 d in the previous lactation (× 5 kg/d)  0.13 0.04 3.18 0.001 1.13 1.05 1.23  
Variable  Variance S.D.      
Random effect 
Herd (Intercept)  0.487 0.698       
a Dry cow therapy. 
b Somatic cell count. 
Table 5 
Model estimates from linear mixed model for the mean somatic cell count (lnSCC × 1000 cells/mL) during 5–120 days in milk (DIM), based on 5695 cows from 239 
dairy herds.  
Variable Category Coefficient S.E. t-value p-value R2GLMM(m)a 95 % CI 
Fixed effects 
Intercept  2.21 0.09 22.20 < 0.0001    
DCTb approach 
No DCT 0.18 0.13 1.40 0.174 0.1 0 0.3 
Blanket DCT − 0.23 0.08 − 2.91 0.002 0.5 0.2 0.9 
Selective DCT Ref.       
Mean lnSCC (× 1000 cells/mL) of the previous lactation  0.36 0.01 21.49 < 0.0001 7.6 6.3 8.9 
Approximated milk production 79 d before calving (× 5 kg/d)  0.08 0.01 6.21 < 0.0001 0.7 0.4 1.3 
Parity 
≥ 4 0.31 0.04 7.64 < 0.0001 1.0 0.5 1.6 
3 0.18 0.04 4.54 < 0.0001 0.3 0.1 0.7 
2 Ref.       
Mastitis treatment within 45 d after calving 
Yes 0.58 0.06 9.43 < 0.0001 1.5 0.9 2.2 
No Ref.        
Variable  Variance S.D.      
Random effect 
Herd (Intercept)  0.113 0.336      
Residual  1.512 1.229       
a The proportion of variance (%) explained by the fixed effects (Nakagawa and Schielzeth, 2013). 
b Dry cow therapy. 
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sustainability concerns. Preferably, the treatment decision of the cow is 
based on longer-term udder health information, and ideally, microbio-
logical analyses of presumably infected quarters is combined to the in-
formation before the decision (Østerås et al., 1999; Torres et al., 2008; 
Cameron et al., 2014; Vasquez et al., 2018). 
The selective-DCT farmers of the current study took frequent 
microbiological milk samples at dry-off (Vilar et al., 2018; Niemi et al., 
2020), which suggests that they often selected the animals for treatment 
based on the results of microbiological samples. The Finnish legislation 
requires that the antibiotic treatment decision and the choice of medi-
cine are based on regular and adequate microbiological analyses 
(Finnish Ministry of Agriculture and Forestry regulation, 2014). Anti-
biotics for dairy farms are available in Finland merely with a veterinary 
prescription, and veterinarians do not have the right to profit from the 
sale of drugs. Thus, the proportion of treated cows in a herd is a joint 
decision of the farmer and the veterinarian. An indication for the use of 
blanket DCT is likely high prevalence of mastitis caused by contagious 
pathogens in a herd. Correspondingly, the most commonly reported 
reason for the no-DCT approach was good udder health (Vilar et al., 
2018), which is supported by the low average herd-level SCC of this 
group (Table 1). Finnish recommendations are briefly as follows: 1) to 
delay the treatment of subclinical mastitis until dry-off, 2) to administer 
DCT to cows with a high SCC, especially during the last three months of 
lactation, based on either DHI measurements or data from automatic 
milking system, and 3) to administer DCT to cows treated for mastitis 
during preceding lactation. In addition, several cow- and 
pathogen-specific advice complement these recommendations and 
emphasize the need for microbiological milk samples. Although analysis 
of milk samples from all cows in a herd is not feasible economically or 
time-wise, regular and comprehensive microbiological milk sampling 
provides essential information on the known causal pathogens in the 
herd (Gussmann et al., 2018b; Ruegg, 2018). By combining information 
about a known pathogen with the onset of infection in relation to the 
lactation stage and the season, the infection pathways can be identified, 
and information on appropriate and effective mastitis prevention mea-
sures in a given herd can be considerably increased. 
Susceptible, recurrently infected cows and chronically infected cows 
are likely to continue having udder health problems after dry period as 
the current results indicate that the cows with a higher long-term SCC 
are more likely to be treated for mastitis and have a higher SCC in the 
subsequent lactation. Moreover, the mean SCC of the previous lactation 
explained most of the variance in the mean SCC after calving compared 
with the other fixed effects. Previous studies support our observations. 
Lipkens et al. (2019b) reported that the lowest test-day SCC throughout 
the next lactation was observed in cows that had a test-day SCC < 200 
000 cell/mL both before and after dry-off. Several studies showed an 
association of higher late-lactation test-day SCC either with increasing 
test-day SCC or increasing likelihood of clinical mastitis in the subse-
quent lactation (Green et al., 2007; Whist and Østerås, 2007; Green 
et al., 2008; Gott et al., 2017; Vanhoudt et al., 2018). The current study 
noticed obvious collinearity between the explanatory variables of the 
preceding lactation udder health, which were mean test-day SCC, last 
test-day SCC, and number of mastitis treatments. Therefore, two out of 
three variables were omitted from the final models. However, all of 
these variables, or combinations of these variables, might be associated 
with the subsequent lactation udder health although their associations 
cannot be assessed simultaneously in the analyses of the current study. 
Susceptibility to recurrent mastitis exists also in quarter-level studies. 
The odds of clinical mastitis were 4.2 times higher in quarters that had a 
clinical mastitis during previous lactation compared with quarters 
without clinical mastitis (Pantoja et al., 2009a). Acquiring new in-
fections during the dry period was more common in cows with a quarter 
already infected at dry-off (Neave et al., 1950; Rindsig et al., 1978; Berry 
and Hillerton, 2002b), and regardless of DCT, quarters infected at 
dry-off had higher odds of having IMI also at calving (Newman et al., 
2010). Persistently infected quarters across the dry period had higher 
odds of clinical mastitis in early lactation compared to healthy quarters 
(Green et al., 2002; Pantoja et al., 2009a), and the occurrence of clinical 
mastitis in early lactation could indicate a mastitis problem that origi-
nated from the dry period (Green et al., 2002). The findings consistently 
emphasize the importance of mastitis prevention in the management of 
udder health, as a cow with a healthy udder is more likely to remain 
healthy in the future. 
Despite a few studies reporting that higher milk yield at dry-off was 
not associated with higher post calving IMI proportion (Natzke et al., 
1975; Gott et al., 2016), a number of studies have shown that IMI shortly 
after calving is more common in cows producing more milk at the point 
of dry-off (Oliver et al., 1956; Dingwell et al., 2004; Rajala-Schultz et al., 
2005; Odensten et al., 2007; Newman et al., 2010). The association 
between the late lactation milk production with udder health of the 
subsequent early lactation, however, is a less-studied issue (Green et al., 
2007, 2008; Madouasse et al., 2012; Gott et al., 2017). In agreement 
with our results, previous studies reported that higher milk production 
at the test-day within 0–30 d before dry-off was associated with an 
increased SCC after calving (Green et al., 2008; Madouasse et al., 2012; 
Gott et al., 2017). Our results showed that milk production at the end of 
lactation was associated with SCC even up to 120 d after calving, as has 
been reported before (Gott et al., 2017). Thus, the results suggest that 
late lactation milk production may have a long-standing influence on the 
early lactation udder health, but an opposite finding also exists. 
Odensten et al. (2007) stated that although milk production at the point 
of dry-off did influence IMI prevalence in the first week after calving, it 
did not influence SCC during the first month after calving. Interestingly, 
the current study found that the high milk production both in the pre-
ceding early and late lactation increased the odds of mastitis treatment 
in the subsequent early lactation. Quite the opposite, Green et al. (2007) 
found that neither 305-d yield nor the milk production at the last 
test-day prior to dry-off influenced the rate of clinical mastitis for a cow. 
Overall, the number of studies supporting that milk production near 
dry-off, or at the point of dry-off, influences the post-parturition udder 
health is more abundant than the number of studies that show other-
wise. The frequently used explanations are that high-yielding cows may 
have incomplete teat-canal closure (Dingwell et al., 2004) and increased 
tendency to leak milk (Schukken et al., 1993; Tucker et al., 2009). Dif-
ferences exist among the studies and results, which is probably due to 
dissimilarity in IMI definitions, study populations, and study designs. 
What is difficult to deduce, is the optimal amount of milk at dry-off and 
the feasible guidance for the farmers. In the majority of previous studies, 
cows received routine blanket DCT at dry-off. To the best of our 
knowledge, this is the first DHI data analysis of the effects of different 
DCT use in herds combined with the information about the milk pro-
duction near dry-off. Worth mentioning is that almost all Finnish farms 
use gradual milk cessation method, and the milk yield of high-yielding 
cows decreases from the last test-day to the point of dry-off, being 
typically 15 kg/d or less (Vilar et al., 2018). Nevertheless, the current 
results showed that higher milk production at the end lactation, instead 
of high peak milk production at the early lactation, was associated with 
the higher post-parturition SCC. 
An older cow is more likely to have mastitis (Dohoo et al., 1981), and 
SCC increases slightly with parity also in uninfected cows (Natzke et al., 
1972). The association is reported repeatedly in numerous studies 
(Dingwell et al., 2004; Whist et al., 2006; Green et al., 2007, 2008; 
Pantoja et al., 2009a). In agreement, the current results showed that 
both the increased odds of having SCC > 200 000 cells / ml at the first 
test-day and the higher mean SCC in early lactation were associated with 
higher parity. Regarding the odds of mastitis treatment, the parity was 
only a confounder for the relationship between peak milk production 
and mastitis. Pantoja et al. (2009a) reported that quarters of cows of 
greater than fourth parity were over four times more likely to have a 
case of clinical mastitis within 120 d after calving than quarters of cows 
of second parity, and higher parity is a potential risk factor for new dry 
period infections (Dingwell et al., 2004). 
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The Holstein breed has been more susceptible to both subclinical and 
clinical mastitis in previous studies (Persson Waller et al., 2009; Heikkilä 
et al., 2012; Hiitiö et al., 2017). Interestingly, the current study did not 
find enough statistical evidence to state that the Holstein breed was 
negatively associated with the early lactation udder health problems 
compared to Finnish Ayrshire breed. Noticeable inter-association was 
lacking between the breed and other variables, and thus the result was 
not due to the collinearity. 
5. Conclusions 
Cows more likely to have high SCC after calving were older cows, 
cows with high average SCC during the previous lactation, and cows 
with high milk yield near dry-off. Selective DCT was the prevailing 
treatment practice in our data. Blanket DCT was associated with lower 
SCC after calving. A mastitis treatment in the early lactation was more 
likely if, during the previous lactation, the cow had high average SCC, 
high peak milk production, or high milk yield near dry-off. Our findings 
indicate that DCT is still effective in mastitis control, however, in the 
light of antimicrobial resistance, it should be practiced in a selective 
manner. Cows with high milk yield, especially near dry-off, and cows 
with persistently high SCC require attention when considering next 
lactation udder health. 
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Bates, D., Mächler, M., Bolker, B., Walker, S., 2015. Fitting linear mixed-effects models 
using lme4. J. Stat. Softw. 67 https://doi.org/10.18637/jss.v067.i01. 
Berry, E.A., Hillerton, E.J., 2002a. The effect of selective dry cow treatment on new 
intramammary infections. J. Dairy Sci. 85, 112–121. https://doi.org/10.3168/jds. 
s0022-0302(02)74059-9. 
Berry, E.A., Hillerton, J.E., 2002b. The effect of an intramammary teat seal on new 
intramammary infections. J. Dairy Sci. 85, 2512–2520. https://doi.org/10.3168/jds. 
s0022-0302(02)74334-8. 
Bradley, A.J., Green, M.J., 2004. The importance of the nonlactating period in the 
epidemiology of intramammary infection and strategies for prevention. Vet. Clin. N. 
Am. Food. A 20, 547–568. https://doi.org/10.1016/j.cvfa.2004.06.010. 
Bradley, A.J., Breen, J.E., Payne, B., Williams, P., Green, M.J., 2010. The use of a 
cephalonium containing dry cow therapy and an internal teat sealant, both alone 
and in combination. J. Dairy Sci. 93, 1566–1577. https://doi.org/10.3168/jds.2009- 
2725. 
Cameron, M., McKenna, S.L., MacDonald, K.A., Dohoo, I.R., Roy, J.P., Keefe, G.P., 2014. 
Evaluation of selective dry cow treatment following on-farm culture: risk of 
postcalving intramammary infection and clinical mastitis in the subsequent 
lactation. J. Dairy Sci. 97, 270–284. https://doi.org/10.3168/jds.2013-7060. 
Cameron, M., Keefe, G.P., Roy, J.P., Stryhn, H., Dohoo, I.R., McKenna, S.L., 2015. 
Evaluation of selective dry cow treatment following on-farm culture: milk yield and 
somatic cell count in the subsequent lactation. J. Dairy Sci. 98, 2427–2436. https:// 
doi.org/10.3168/jds.2014-8876. 
Cook, N.B., Bennett, T.B., Emery, K.M., Nordlund, K.V., 2002. Monitoring nonlactating 
cow intramammary infection dynamics using DHI somatic cell count data. J. Dairy 
Sci. 85, 1119–1126. https://doi.org/10.3168/jds.s0022-0302(02)74173-8. 
De Jong, A., Garch, F.E., Simjee, S., Moyaert, H., Rose, M., Youala, M., Siegwart, E., 
VetPath Study Group, 2018. Monitoring of antimicrobial susceptibility of udder 
pathogens recovered from cases of clinical mastitis in dairy cows across Europe: 
VetPath results. Vet. Microbiol. 213, 73–81. https://doi.org/10.1016/j. 
vetmic.2017.11.021. 
Dingwell, R.T., Kelton, D.F., Leslie, K.E., 2003. Management of the dry cow in control of 
peripartum disease and mastitis. Vet. Clin. N. Am. Food A 19, 235–265. https://doi. 
org/10.1016/S0749-0720(02)00072-5. 
Dingwell, R.T., Leslie, K.E., Schukken, Y.H., Sargeant, J.M., Timms, L.L., Duffield, T.F., 
Keefe, G.P., Kelton, D.F., Lissemore, K.D., Conklin, J., 2004. Association of cow and 
quarter-level factors at drying-off with new intramammary infections during the dry 
period. Prev. Vet. Med. 63, 75–89. https://doi.org/10.1016/j. 
prevetmed.2004.01.012. 
Djabri, B., Bareille, N., Beaudeau, F., Seegers, H., 2002. Quarter milk somatic cell count 
in infected dairy cows: a meta-analysis. Vet. Res. 33, 335–357. https://doi.org/ 
10.1051/vetres:2002021. 
Dohoo, I.R., Leslie, K.E., 1991. Evaluation of changes in SCC as indicators of new 
intramammary infections. Prev. Vet. Med. 10, 225–237. https://doi.org/10.1016/ 
0167-5877(91)90006-n. 
Dohoo, I.R., Meek, A.H., Martin, S.W., Barnum, D.A., 1981. Use of total and differential 
somatic cell counts from composite milk samples to detect mastitis in individual 
cows. Can. J. Comp. Med. 45, 8–14. 
Dufour, S., Dohoo, I.R., 2012. Monitoring dry period intramammary infection incidence 
and elimination rates using somatic cell count measurements. J. Dairy Sci. 95, 
7173–7185. https://doi.org/10.3168/jds.2012-5839. 
Ekman, T., Østerås, O., 2003. Mastitis control and dry cow therapy in the Nordic 
countries. In: In, Natl. Mastitis Counc. Ann. Mtg. Forth Worth, Texas, pp. 18–30. 
EMA, EFSA, 2017. EMA and EFSA Joint Scientific Opinion on measures to reduce the 
need to use antimicrobial agents in animal husbandry in the European Union, and 
the resulting impacts on food safety. EFSA J. 15, 4666. https://doi.org/10.2903/j. 
efsa.2017.4666. 
European Commission, 2015. Commission Notice: guidelines for the prudent use of 
antimicrobials in veterinary medicine. No C 299/04. Off. J. Eur. Union C 299, 7–26 
(accessed 1 December 2020). https://ec.europa.eu/health/sites/health/files/antim 
icrobial_resistance/docs/2015_prudent_use_guidelines_en.pdf. 
Finnish Ministry of Agriculture and Forestry regulation, 2014. The Use and Supply of 
Medicinal Products in Veterinary Medicine. No 17/14. https://mmm.fi/documents/ 
1410837/1817140/Laakkeiden_luovutus_.pdf/a7ff23f1-83f0-4a3e-9bf5-51babbfc83 
7a. 
Gott, P.N., Rajala-Schultz, P.J., Schuenemann, G.M., Proudfoot, K.L., Hogan, J.S., 2016. 
Intramammary infections and milk leakage following gradual or abrupt cessation of 
milking. J. Dairy Sci. 99, 4005–4017. https://doi.org/10.3168/jds.2015-10348. 
Gott, P.N., Rajala-Schultz, P.J., Schuenemann, G.M., Proudfoot, K.L., Hogan, J.S., 2017. 
Effect of gradual or abrupt cessation of milking at dry off on milk yield and somatic 
cell score in the subsequent lactation. J. Dairy Sci. 100, 2080–2089. https://doi.org/ 
10.3168/jds.2016-11444. 
Green, J.T., Green, L.E., Medley, G.F., Schukken, Y.H., Bradley, A.J., 2002. Influence of 
dry period bacterial intramammary infection on clinical mastitis in dairy cows. 
J. Dairy Sci. 85, 2589–2599. https://doi.org/10.3168/jds.S0022-0302(02)74343-9. 
Green, M.J., Bradley, A.J., Medley, G.F., Browne, W.J., 2007. Cow, farm, and 
management factors during the dry period that determine the rate of clinical mastitis 
after calving. J. Dairy Sci. 90, 3764–3776. https://doi.org/10.3168/jds.2007-0107. 
Green, M.J., Bradley, A.J., Medley, G.F., Browne, W.J., 2008. Cow, farm, and herd 
management factors in the dry period associated with raised somatic cell counts in 
early lactation. J. Dairy Sci. 91, 1403–1415. https://doi.org/10.3168/jds.2007- 
0621. 
Gussmann, M., Graesboll, K., Toft, N., Nielsen, S.S., Farre, M., Kirkeby, C., Halasa, T., 
2018a. Determinants of antimicrobial treatment for udder health in Danish dairy 
cattle herds. J. Dairy Sci. 101, 505–517. https://doi.org/10.3168/jds.2017-12994. 
Gussmann, M., Steeneveld, W., Kirkeby, C., Hogeveen, H., Nielen, M., Farre, M., 
Halasa, T., 2018b. Economic and epidemiological impact of different intervention 
strategies for clinical contagious mastitis. J. Dairy Sci. 102, 1483–1493. https://doi. 
org/10.3168/jds.2018-14939. 
Halasa, T., Huijps, K., Østerås, O., Hogeveen, H., 2007. Economic effects of bovine 
mastitis and mastitis management: a review. Vet. Quart. 29, 18–31. https://doi.org/ 
10.1080/01652176.2007.9695224. 
Halasa, T., Østerås, O., Hogeveen, H., van Werven, T., Nielen, M., 2009. Meta-analysis of 
dry cow management for dairy cattle. Part 1. Protection against new intramammary 
infections. J. Dairy Sci. 92, 3134–3149. https://doi.org/10.3168/jds.2008-1740. 
Halasa, T., Nielen, M., van Werven, T., Hogeveen, H., 2010. A simulation model to 
calculate costs and benefits of dry period interventions in dairy cattle. Livest. Sci. 
129, 80–87. https://doi.org/10.1016/j.livsci.2010.01.009. 
Heikkilä, A.-M., Nousiainen, J.I., Pyörälä, S., 2012. Costs of clinical mastitis with special 
reference to premature culling. J. Dairy Sci. 95, 139–150. https://doi.org/10.3168/ 
jds.2011-4321. 
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